Atlas Trials

Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma

Clinical trial NCT00284271 · COMPLETED

Trial details

NCT number
NCT00284271
Sponsor
University of Cologne
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hodgkin´s Lymphoma
Start date
2004-01-01
Primary completion
2005-12-01
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.